CRISPR Therapeutics AGCRSPNASDAQ
LOADING
|||
Switch Symbol:
Gross Profit Over Time
Trending lower, below historical average, strong compound growth.
Left:
||||
Revenue minus cost of goods sold
Latest
$-75.25M
↓ 245% below average
Average (9y)
$51.93M
Historical baseline
Range
High:$811.90M
Low:$-268.69M
CAGR
+22.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-75.25M | -131.4% |
| 2023 | $239.75M | +318.3% |
| 2022 | $-109.81M | -113.5% |
| 2021 | $811.90M | +402.2% |
| 2020 | $-268.69M | -343.8% |
| 2019 | $110.23M | +199.6% |
| 2018 | $-110.65M | -284.2% |
| 2017 | $-28.80M | +22.3% |
| 2016 | $-37.07M | -200.8% |
| 2015 | $-12.33M | - |